![Orgad Laub](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Orgad Laub
Chief Executive Officer at Sealantium Medical Ltd.
Orgad Laub active positions
Companies | Position | Start | End |
---|---|---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Director/Board Member | - | - |
Sealantium Medical Ltd.
![]() Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Chief Executive Officer | 2010-12-31 | - |
Founder | 2010-12-31 | - |
Career history of Orgad Laub
Former positions of Orgad Laub
Companies | Position | Start | End |
---|---|---|---|
Serono Corp. | Director/Board Member | - | - |
Weizmann Institute of Science | Corporate Officer/Principal | - | - |
Statistics
International
Israel | 5 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
Serono Corp. | |
Sealantium Medical Ltd.
![]() Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Health Technology |
- Stock Market
- Insiders
- Orgad Laub
- Experience